GSI 255 (Odefsey emtricitabine 200 mg / rilpivirine 25 mg / tenofovir alafenamide 25 mg)
Generic Name: emtricitabine/rilpivirine/tenofovir alafenamide
Pill with imprint GSI 255 is Gray, Capsule-shape and has been identified as Odefsey emtricitabine 200 mg / rilpivirine 25 mg / tenofovir alafenamide 25 mg. It is supplied by Gilead Sciences, Inc..
Odefsey is used in the treatment of hiv infection and belongs to the drug class antiviral combinations. Odefsey emtricitabine 200 mg / rilpivirine 25 mg / tenofovir alafenamide 25 mg is not a controlled substance under the Controlled Substance Act (CSA).
Images for GSI 255
Odefsey
- Generic Name:
- emtricitabine/rilpivirine/tenofovir alafenamide
- Imprint:
- GSI 255
- Strength:
- emtricitabine 200 mg / rilpivirine 25 mg / tenofovir alafenamide 25 mg
- Color:
- Gray
- Shape:
- Capsule-shape
- Availability:
- Prescription only
- Drug Class:
- Antiviral combinations
- CSA Schedule:
- Not a controlled drug
- Labeler / Supplier:
- Gilead Sciences, Inc.
- National Drug Code (NDC):
- 61958-2101
More about Odefsey (emtricitabine / rilpivirine / tenofovir alafenamide)
- Side Effects
- During Pregnancy
- Dosage Information
- Drug Images
- Drug Interactions
- Support Group
- Pricing & Coupons
- 3 Reviews – Add your own review/rating
- Drug class: antiviral combinations
Consumer resources
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2018 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
